FindTrial
Sign In

Pharmacodynamics of rocuronium and cisatracurium in patients with different body fat rates

Pharmacodynamics of rocuronium and cisatracurium in patients with different body fat rates

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026743
Enrollment
Unknown
Registered
2019-10-20
Start date
2019-10-15
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

different body fat index

Interventions

R-Total body weight:dose of Rocuronium is calculated by the total body weight
R-fat-free weight:Rocuronium dose is calculated by the fat-free weight
C-total body weight:dose of Cisatracurium is calculated by the total body weight
C--fat-free weight:dose of Cisatracurium is calculated by the fat-free weight

Sponsors

Shanghai Gengeral Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients ASA physical status I-II, aged 18-65 years, scheduled for selective non-cardiac surgery, Body fat index 10-50.

Exclusion criteria

Exclusion criteria: BMI30, a history of alcohol or drug abuse, or with heart dysfunctionshepatic disease or nephropathy.

Design outcomes

Primary

MeasureTime frame
drug onset time;Body fat index;TOF;Clinical duration;recovery index;recovery time;—

Secondary

MeasureTime frame
Blood pressure;Heart Rate;—

Countries

China

Contacts

Public ContactAn Guanghui

Shanghai General Hospital

gh_An@163.com+86 13764122642

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026